Skip to main content
رجوع
Watch Compare

Curanex Pharmaceuticals Inc

جودة البيانات: 83%
CURX
Nasdaq Manufacturing Chemicals
KWD 0.47
▲ KWD 0.03 (5.63%)
القيمة السوقية: 13.28 M
السعر
KWD 0.47
القيمة السوقية
13.28 M
نطاق اليوم
KWD 0.43 — KWD 0.48
نطاق 52 أسبوعًا
KWD 0.26 — KWD 9.18
حجم التداول
82,720
فتح KWD 0.44
متوسط 50 يوم / 200 يوم
KWD 0.39
21.50% above
متوسط 50 يوم / 200 يوم
KWD 1.13
58.47% below

Quick Summary

النقاط الرئيسية

Negative free cash flow of -10.48 M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-57.89%
أقل من متوسط القطاع (-53.41%)
ROIC-44.64%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
N/A
Current Ratio77.53
Interest Coverage-496.55

التقييم

PE (TTM)
-3.14
أقل من متوسط القطاع (-1.48)
P/B Ratio0.93
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (1364 نظير)
المقياس السهم وسيط القطاع
P/E -3.1 -1.5
P/B 0.9 1.6
ROE % -57.9 -53.4
Net Margin % — -41.5
Rev Growth 5Y % — 1.8
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) N/A Net Income (TTM) -4.23 M
ROE -57.89% ROA -55.36%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -10.48 M
ROIC -44.64% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 77.53
Interest Coverage -496.55 Asset Turnover N/A
Working Capital 14.23 M Tangible Book Value 14.29 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -3.14 Forward P/E N/A
P/B Ratio 0.93 P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -78.93%
Market Cap 13.28 M Enterprise Value 7.48 M
Per Share
EPS (Diluted TTM) -0.17 Revenue / Share N/A
FCF / Share -0.37 OCF / Share -0.37
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 248.15%
SBC-Adj. FCF N/A Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025
Revenue —
Net Income -4.23 M
EPS (Diluted) -0.17
Gross Profit —
Operating Income -4.24 M
EBITDA —
R&D Expenses 2.99 M
SG&A Expenses —
D&A —
Interest Expense 8,537.0
Income Tax —

Balance Sheet

Annual, most recent first
Metric FY2025
Total Assets 11.58 M
Total Liabilities 361,040.0
Shareholders' Equity 11.22 M
Total Debt —
Cash & Equivalents 5.00 M
Current Assets 11.23 M
Current Liabilities 137,030.0